Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer
https://www.nature.com/articles/s43018-021-00280-y
Metastatic research really needs more funding. It's the true killing mechanism of cancer, and when this can be controlled, metastatic cancer can be classified as a chronic condition, not a terminal one.
Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis https://www.nature.com/articles/s43018-021-00279-5
Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer https://www.nature.com/articles/s43018-021-00280-y